logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Tamas Hickish

University of Bristol
H指数:58
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy, safety, and quality-of-life improvement of chemotherapy regimens for treatment of unresectable pancreatic cancer: a systematic review and network meta-analysis of phase III randomised controlled trials

不可切除胰腺癌化疗方案的有效性、安全性和生活质量改善：一项基于III期随机对照试验的系统评价和网络Meta分析

Heliyon
IF3.6
2026-08-010
OAAI
Ezeh, Ejike T.; Welton, Nicky J.; Primrose, John; Hickish, Tamas; Porter, Sam; Scammell, Janet; Jiang, Nan
Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy Post Hoc Analysis of the SCOT Randomized Clinical Trial

从结直肠癌手术到辅助化疗的时间SCOT随机临床试验的事后分析

JAMA SURGERY
IF14.9
2024-08-011
PRE
Gogenur, Mikail; Rosen, Andreas Weinberger; Iveson, Timothy; Kerr, Rachel S.; Saunders, Mark P.; Cassidy, Jim; Tabernero, Josep; Haydon, Andrew; Glimelius, Bengt; Harkin, Andrea; Allan, Karen; Pearson, Sarah; Boyd, Kathleen A.; Briggs, Andrew H.; Waterston, Ashita; Medley, Louise; Ellis, Richard; Dhadda, Amandeep S.; Harrison, Mark; Falk, Stephen; Rees, Charlotte; Olesen, Rene K.; Propper, David; Bridgewater, John; Azzabi, Ashraf; Cunningham, David; Hickish, Tamas; Gollins, Simon; Wasan, Harpreet S.; Kelly, Caroline; Goegenur, Ismail; Hollaender, Niels Henrik
PARTNER Trial: Neoadjuvant olaparib in triple negative breast cancer (TNBC)
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Abraham, Jean E.; Pinilla, Karen; Grybowicz, Louise; Dayimu, Alimu; Demiris, Nikolaos; Harvey, Caron; Drewett, Lynsey M.; Lucey, Rebecca; Fulton, Alexander; Roberts, Anne N.; Worley, Joanna R.; Chhabra, Anita; Qian, Wendi; Hardy, Richard M.; Chan, Stephen; Hickish, Tamas; Tripathi, Devashish; Venkitaraman, Ramachandran; Persic, Mojca; Aslam, Shahzeena; Glassman, Daniel; Raj, Sanjay; Borley, Annabel; Braybrooke, Jeremy P.; Sutherland, Stephanie; Staples, Emma; Scott, Lucy C.; Davies, Mark; Palmer, Cheryl A.; Moody, Margaret; Churn, Mark J.; Newby, Jacqueline C.; Mukesh, B. Mukesh; Chakrabarti, Amitabha; Roylance, Rebecca R.; Schouten, Philip C.; Levitt, Nicola; McAdam, Karen; Armstrong, Anne C.; Copson, Ellen R.; McMurtry, Emma; Tischkowitz, Marc; Provenzano, Elena; Earl, Helena
Tracking triple negative breast cancer (TNBC) evolution in the molecular residual disease (MRD) setting in the c-TRAK TN clinical trial
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Coakley, Maria; Cutts, Rosalind J.; Sritharan, Prithika; Hrebien, Sarah; Swift, Claire; Dunne, Kathryn; Kilburn, Lucy; Goddard, Katie; Villacampa, Guillermo; Rojas, Patricia; Emmett, Warren; Pipinikas, Christodoulos; Hall, Peter; Harper-Wynne, Catherine; Hickish, Tamas; Macpherson, Iain; Okines, Alicia; Wardley, Andrew; Wheatley, Duncan; Waters, Simon; Bliss, Judith M.; Garcia-Murillas, Isaac; Turner, Nicholas C.
Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer
CLINICAL CANCER RESEARCH
IF10.2
2023-12-110
OAAI
Coakley, Maria; Villacampa, Guillermo; Sritharan, Prithika; Swift, Claire; Dunne, Kathryn; Kilburn, Lucy; Goddard, Katie; Pipinikas, Christodoulos; Rojas, Patricia; Emmett, Warren; Hall, Peter; Harper-Wynne, Catherine; Hickish, Tamas; Macpherson, Iain; Okines, Alicia; Wardley, Andrew; Wheatley, Duncan; Waters, Simon; Palmieri, Carlo; Winter, Matthew; Cutts, Rosalind J.; Garcia-Murillas, Isaac; Bliss, Judith; Turner, Nicholas C.
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)
CLINICAL CANCER RESEARCH
IF10.2
2023-09-294
OAAI
Ring, Alistair; Kilburn, Lucy S.; Pearson, Alex; Moretti, Laura; Afshari-Mehr, Angelica; Wardley, Andrew M.; Gurel, Bora; Macpherson, Iain R.; Riisnaes, Ruth; Baird, Richard D.; Martin, Sue; Roylance, Rebecca; Johnson, Hannah; Ferreira, Ana; Winter, Matthew C.; Dunne, Kathryn; Copson, Ellen; Hickish, Tamas; Burcombe, Russell; Randle, Kat; Serra, Violeta; Llop-Guevara, Alba; Bliss, Judith M.; Turner, Nicolas C.
A UK prospective multicentre decision impact, decision conflict and economic evaluation of the use of Oncotype DX® to guide chemotherapy in 680 women with hormone receptor positive, HER2 negative breast cancer and 1 to 3 nodes involved
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Holt, Simon D.; Sai-Giridhar, Priyadharshini; Verrill, Mark; Pettit, Laura; Rigg, Anna; Hickish, Tamas; Archer, Caroline D.; Wadhawan, Anshu; Dillon, Marianne; Dent, Jo; Nathan, Mark R.; Barthelmes, Ludger; Rehman, Shazza; Innis, Paige; Khawaja, Saira
Comparison of a personalized sequencing assay and digital PCR for circulating tumor DNA based Molecular Residual Disease detection in early-stage triple negative breast cancer in the cTRAK-TN trial
CANCER RESEARCH
IF16.6
2023-03-011
PRE
Coakley, Maria; Sritharan, Prithika; Villacampa, Guillermo; Swift, Claire; Dunne, Kathryn; Kilburn, Lucy; Goddard, Katie; Rojas, Patricia; Joad, Andy; Emmett, Warren; Knape, Charlene; Howarth, Karen; Hall, Peter S.; Harper-Wynne, Catherine; Hickish, Tamas; Macpherson, Iain; Okines, Alicia F.; Wardley, Andrew M.; Wheatley, Duncan; Waters, Simon; Cutts, Rosalind; Garcia-Murillas, Isaac; Bliss, Judith; Turner, Nicholas
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer
ANNALS OF ONCOLOGY
IF65.4
2023-02-0164
OAAI
Turner, N. C.; Swift, C.; Jenkins, B.; Kilburn, L.; Coakley, M.; Beaney, M.; Fox, L.; Goddard, K.; Garcia-Murillas, I.; Proszek, P.; Hall, P.; Harper-Wynne, C.; Hickish, T.; Kernaghan, S.; Macpherson, I. R.; Okines, A. F. C.; Palmieri, C.; Perry, S.; Randle, K.; Snowdon, C.; Stobart, H.; Wardley, A. M.; Wheatley, D.; Waters, S.; Winter, M. C.; Hubank, M.; Allen, S. D.; Bliss, J. M.
Primary results of the cTRAK TN trial: A clinical trial utilising ctDNA mutation tracking to detect minimal residual disease and trigger intervention in patients with moderate and high risk early stage triple negative breast cancer
CANCER RESEARCH
IF16.6
2022-02-1510
PRE
Turner, Nicholas; Swift, Claire; Jenkins, Ben; Kilburn, Lucy; Coakley, Maria; Beaney, Matthew; Fox, Lisa; Goddard, Katie; Garcia-Murillas, Isaac; Hall, Peter; Harper-Wynne, Catherine; Hickish, Tamas; Kernaghan, Sarah; Macpherson, Iain; Okines, Alicia; Palmieri, Carlo; Perry, Sophie; Randle, Katrina; Snowdon, Claire; Stobart, Hilary; Wardley, Andrew; Wheatley, Duncan; Waters, Simon; Winter, Matthew; Bliss, Judith
Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial
BREAST CANCER RESEARCH AND TREATMENT
IF3
2022-02-0910
OAAI
Hickish, Tamas; Mehta, Ajay; Liu, Mei-Ching; Huang, Chiun-Sheng; Arora, Rajendra Singh; Chang, Yuan-Ching; Yang, Youngsen; Vladimirov, Vladimir; Jain, Minish; Tsang, Janice; Pemberton, Karine; Sadrolhefazi, Behbood; Jin, Xidong; Tseng, Ling-Ming
Impact of the Oncotype DX breast cancer assay on treatment decisions in a UK population of patients with oestrogen receptor positive early breast cancer with 1-3 lymph nodes positive who are candidates for chemotherapy, but for whom the benefits are uncertain - Interim results
CANCER RESEARCH
IF16.6
2020-02-152
PRE
Thomas, Daniel; Maxwell, William; Archer, Caroline; Rigg, Anne; Hickish, Tamas; Dent, Jo; Pettit, Laura; Dillon, Marianne; Goldsmith, Christy; Verrill, Mark; Barthelmes, Ludger; Khawaja, Saira; Sharaiha, Yousef; Davies, Mark; Arikat, Fawaz; Khan, Sahail; Munir, Asma; Huws, Anita; Holt, Simon DavidHenry
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT
HEALTH TECHNOLOGY ASSESSMENT
IF4
2019-12-0126
OA
Ivesono, Timothy; Boydo, Kathleen A.; Kerro, Rachel S.; Robles-Zuritao, Jose; Saunders, Mark P.; Briggso, Andrew H.; Cassidyo, Jim; Hollandero, Niels Henrik; Taberneroo, Josep; Haydon, Andrew; Glimeliuso, Bengt; Harkino, Andrea; Allano, Karen; McQueeno, John; Pearsono, Sarah; Waterstono, Ashita; Medleyo, Louise; Wilsono, Charles; Elliso, Richard; Essapen, Sharadah; Dhaddao, Amandeep S.; Harrison, Mark; Falko, Stephen; Raoufo, Sherif; Rees, Charlotte; Oleseno, Rene K.; Proppero, David; Bridgewatero, John; Azzabio, Ashraf; Farrugiao, David; Webbo, Andrew; Cunninghamo, David; Hickish, Tamas; Weavero, Andrew; Gollins, Simon; Wasano, Harpreet; Paulo, James
Survival outcomes of the NeoALTTO study (BIG 1-06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer

NeoALTTO研究 (BIG 1-06) 的生存结果: HER2-positive原发性乳腺癌患者的随机多中心III期新辅助临床试验的更新结果

EUROPEAN JOURNAL OF CANCER
IF7.1
2019-09-0164
OAAI
Huober, Jens; Holmes, Eileen; Baselga, Jose; de Azambuja, Evandro; Untch, Michael; Fumagalli, Debora; Sarp, Severine; Lang, Istvan; Smith, Ian; Boyle, Frances; Xu, Binghe; Lecocq, Christophe; Wildiers, Hans; Jouannaud, Christelle; Hackman, John; Dasappa, Lokanatha; Ciruelos, Eva; Toral Pena, Juan Carlos; Adamchuk, Hryhoriy; Hickish, Tamas; de la Pena, Lorena; Jackisch, Christian; Gelber, Richard D.; Piccart-Gebhart, Martine; Di Cosimo, Serena

研究方向

暂未获取到该数据
D
David Cunningham
H 指数:153论文数:2,060被引数:13.0万
T
Timothy Iveson
H 指数:52论文数:188被引数:3.0万
I
Ian Chau
H 指数:81论文数:850被引数:4.5万
J
Josep Tabernero
H 指数:146论文数:2,711被引数:12.7万
J
Judith M. Bliss
H 指数:90论文数:805被引数:3.8万
D
Duncan Wheatley
H 指数:34论文数:185被引数:8,626
K
Karen McAdam
H 指数:21论文数:80被引数:2,585
A
A. Norman
H 指数:64论文数:261被引数:1.6万
P
Paul J. Ross
H 指数:61论文数:397被引数:2.3万
L
Lucy Kilburn
H 指数:31论文数:327被引数:7,303